ICU Medical (NASDAQ:ICUI) Sets New 52-Week High – What’s Next?

ICU Medical, Inc. (NASDAQ:ICUI)’s share price reached a new 52-week high on Monday . The company traded as high as $174.77 and last traded at $174.8530, with a volume of 20705 shares. The stock had previously closed at $168.51.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ICUI shares. Sanford C. Bernstein downgraded shares of ICU Medical to a “market perform” rating in a report on Monday, June 15th. Weiss Ratings upgraded ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 23rd. Piper Sandler decreased their price objective on ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Needham & Company LLC raised ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 price objective for the company in a research note on Wednesday, May 27th. Finally, BTIG Research began coverage on ICU Medical in a report on Monday, June 15th. They issued a “buy” rating and a $170.00 target price for the company. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $172.00.

ICU Medical Stock Down 0.6%

The company’s fifty day moving average price is $149.55 and its 200-day moving average price is $140.57. The stock has a market cap of $4.30 billion, a P/E ratio of 92.95, a price-to-earnings-growth ratio of 2.42 and a beta of 0.74. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 2.34.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.19. The firm had revenue of $525.77 million during the quarter, compared to analysts’ expectations of $520.65 million. ICU Medical had a net margin of 2.15% and a return on equity of 7.50%. The firm’s revenue for the quarter was down 12.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Equities analysts forecast that ICU Medical, Inc. will post 6.51 EPS for the current year.

Insider Activity

In other news, VP Virginia Ruth Sanzone sold 2,447 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $124.08, for a total transaction of $303,623.76. Following the transaction, the vice president owned 19,460 shares of the company’s stock, valued at approximately $2,414,596.80. This represents a 11.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director David C. Greenberg sold 2,424 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total value of $297,933.84. Following the completion of the sale, the director owned 7,960 shares in the company, valued at approximately $978,363.60. The trade was a 23.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On ICU Medical

Large investors have recently bought and sold shares of the business. Hilton Head Capital Partners LLC purchased a new stake in ICU Medical in the fourth quarter worth $32,000. Covestor Ltd boosted its stake in shares of ICU Medical by 22.1% during the fourth quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock valued at $99,000 after purchasing an additional 126 shares during the period. Strs Ohio boosted its stake in shares of ICU Medical by 60.0% during the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 300 shares during the period. Rockefeller Capital Management L.P. grew its holdings in shares of ICU Medical by 21.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock worth $117,000 after purchasing an additional 146 shares during the last quarter. Finally, Kemnay Advisory Services Inc. bought a new position in shares of ICU Medical in the fourth quarter worth about $120,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.